STANDARD BIOTOOLS INC. — Director's Dealing 2013

Sep 5, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2013-09-03

Reporting Person: Smith William Maxwell (EVP, LEGAL AFFAIRS & GC)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-09-03	Common Stock	M	5000	$4.4461	Acquired	5000	Direct
2013-09-03	Common Stock	S	5000	$20.436	Disposed	0	Direct
2013-09-03	Common Stock	M	2000	$15.49	Acquired	2000	Direct
2013-09-03	Common Stock	S	2000	$20.3746	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-09-03	Employee Stock Option (Right to Buy)	$4.4461	M	5000	Disposed	2017-05-07	Common Stock (5000)	Direct
2013-09-03	Employee Stock Option (Right to Buy)	$15.49	M	2000	Disposed	2022-02-17	Common Stock (2000)	Direct

Footnotes

F1: The sales reported by Mr. Smith were effected pursuant to a Rule 10b5-1 trading plan adopted on November 28, 2012.

F2: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $20.23 to $20.76, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $20.22 to $20.61, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F4: The shares subject to the Option fully vested on May 1, 2011.

F5: 1/48 of the shares subject to the Option vested on the date of grant and 1/48 of the shares subject to the Option vested on March 1, 2012 and each month thereafter, such that the Option will be fully vested on January 1, 2016.